2022 was a record year for marijuana research, with over 4,300 studies published on marijuana and its components.
“We need more research” is easily one of the most common refrains from reform opponents, who insist that cannabis is understudied even though it’s one of the most frequently researched medical subjects. Scientists’ interest in studying cannabis has increased exponentially in recent years bringing with it an increased understanding of the plant, its active constituents, mechanisms of action, and effects on both the user and society.
Lawmakers and legalization advocates have continually supported expanded research into cannabis which won a major victory this year with President Biden’s historic marijuana research bill that will streamline studies moving forward.
“It is time for politicians and others to stop assessing cannabis through the lens of ‘what we don’t know and instead start engaging in evidence-based discussions about marijuana and marijuana reform policies that are indicative of all that we do know,” – NORML Deputy Director Paul Armentano.